134 related articles for article (PubMed ID: 32787271)
41. Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b+ dendritic cells in nasal tissue.
Sun X; Hosomi K; Shimoyama A; Yoshii K; Saika A; Yamaura H; Nagatake T; Kiyono H; Fukase K; Kunisawa J
Int Immunol; 2024 Jan; 36(1):33-43. PubMed ID: 38006376
[TBL] [Abstract][Full Text] [Related]
42. Polymeric Caffeic Acid Acts as an Antigen Delivery Carrier for Mucosal Vaccine Formulation by Forming a Complex with an Antigenic Protein.
Tada R; Nagai Y; Ogasawara M; Saito M; Ohshima A; Yamanaka D; Kunisawa J; Adachi Y; Negishi Y
Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793700
[TBL] [Abstract][Full Text] [Related]
43. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines.
Criscuolo E; Caputo V; Diotti RA; Sautto GA; Kirchenbaum GA; Clementi N
J Immunol Res; 2019; 2019():8303648. PubMed ID: 30949518
[TBL] [Abstract][Full Text] [Related]
44. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant.
Casella CR; Mitchell TC
Cell Mol Life Sci; 2008 Oct; 65(20):3231-40. PubMed ID: 18668203
[TBL] [Abstract][Full Text] [Related]
45. An RNA-Scaffold Protein Subunit Vaccine for Nasal Immunization.
Lam JY; Wong WM; Yuen CK; Ng YY; San CH; Yuen KY; Kok KH
Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896953
[TBL] [Abstract][Full Text] [Related]
46. Metabolic engineering of Escherichia coli to produce a monophosphoryl lipid A adjuvant.
Ji Y; An J; Hwang D; Ha DH; Lim SM; Lee C; Zhao J; Song HK; Yang EG; Zhou P; Chung HS
Metab Eng; 2020 Jan; 57():193-202. PubMed ID: 31786244
[TBL] [Abstract][Full Text] [Related]
47. Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles.
Najafi A; Ghazvini K; Sankian M; Gholami L; Zare S; Yousefi Arvand A; Tafaghodi M
Iran J Basic Med Sci; 2023; 26(10):1162-1167. PubMed ID: 37736514
[TBL] [Abstract][Full Text] [Related]
48. Monophosphoryl Lipid A-based Adjuvant to Promote the Immunogenicity of Multivalent Meningococcal Polysaccharide Conjugate Vaccines.
Alugupalli KR
Immunohorizons; 2024 Apr; 8(4):317-325. PubMed ID: 38625118
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the protective effect of the intranasal vaccines adjuvanted with bacterium-like particles against intestinal infection.
Tsujii A; Takahashi K; Harada H; Kawashima S; Oikawa H; Fukushima H; Hayakawa Y; Koizumi J; Inoue N; Koshizuka T
Vaccine; 2024 May; ():. PubMed ID: 38763852
[TBL] [Abstract][Full Text] [Related]
50. Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT
Heath MD; Mohsen MO; de Kam PJ; Carreno Velazquez TL; Hewings SJ; Kramer MF; Kündig TM; Bachmann MF; Skinner MA
Front Immunol; 2020; 11():594911. PubMed ID: 33324411
[TBL] [Abstract][Full Text] [Related]
51. Molecular Events in Immune Responses to Sublingual Influenza Vaccine with Hemagglutinin Antigen and Poly(I:C) Adjuvant in Nonhuman Primates, Cynomolgus Macaques.
Yamamoto T; Hirano M; Mitsunaga F; Wasaki K; Kotani A; Tajima K; Nakamura S
Vaccines (Basel); 2024 Jun; 12(6):. PubMed ID: 38932372
[TBL] [Abstract][Full Text] [Related]
52. Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines.
Dalla Pietà A; Carpanese D; Grigoletto A; Tosi A; Dalla Santa S; Pedersen GK; Christensen D; Meléndez-Alafort L; Barbieri V; De Benedictis P; Pasut G; Montagner IM; Rosato A
Cell Mol Immunol; 2021 May; 18(5):1197-1210. PubMed ID: 33762685
[TBL] [Abstract][Full Text] [Related]
53. Development of a Modular NTA:His Tag Viral Vaccine for Co-delivery of Antigen and Adjuvant.
Chung YH; Volckaert BA; Steinmetz NF
Bioconjug Chem; 2023 Jan; 34(1):269-278. PubMed ID: 36608270
[TBL] [Abstract][Full Text] [Related]
54. Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment.
Tockary TA; Abbasi S; Matsui-Masai M; Hayashi A; Yoshinaga N; Boonstra E; Wang Z; Fukushima S; Kataoka K; Uchida S
Proc Natl Acad Sci U S A; 2023 Jul; 120(29):e2214320120. PubMed ID: 37428918
[TBL] [Abstract][Full Text] [Related]
55. Novel nucleotide-packaging vaccine delivers antigen and poly(I:C) to dendritic cells and generate a potent antibody response in vivo.
Bruun N; Laursen MF; Carmelo R; Christensen E; Jensen TS; Christiansen G; Birkelund S; Agger R; Kofod-Olsen E
Vaccine; 2024 Apr; 42(11):2909-2918. PubMed ID: 38538405
[TBL] [Abstract][Full Text] [Related]
56. Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth.
He L; Bai Y; Xia L; Pan J; Sun X; Zhu Z; Ding J; Qi C; Tang C
Cancer Immunol Immunother; 2022 Aug; 71(8):2007-2028. PubMed ID: 34982184
[TBL] [Abstract][Full Text] [Related]
57. Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants.
Sevimli S; Knight FC; Gilchuk P; Joyce S; Wilson JT
ACS Biomater Sci Eng; 2017 Feb; 3(2):179-194. PubMed ID: 29046894
[TBL] [Abstract][Full Text] [Related]
58. GFPBW1, a β-glucan from Grifola frondosa as vaccine adjuvant: APCs activation and maturation.
He X; Lu JL; Liao WF; Long YR; Zhang X; Zhu Q; Lu HL; Hao GY; Ding K; Sun JH; Gong LK; Yang YF
Acta Pharmacol Sin; 2024 Jun; ():. PubMed ID: 38907048
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for
Abhyankar MM; Orr MT; Lin S; Suraju MO; Simpson A; Blust M; Pham T; Guderian JA; Tomai MA; Elvecrog J; Pedersen K; Petri WA; Fox CB
NPJ Vaccines; 2018; 3():22. PubMed ID: 29900011
[TBL] [Abstract][Full Text] [Related]
60. Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant.
Kim KS; Kim H; Park Y; Kong WH; Lee SW; Kwok SJ; Hahn SK; Yun SH
Adv Funct Mater; 2016 Apr; 26(15):2512-2522. PubMed ID: 27833475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
